The Signs and Symptoms of Ovarian Cancer including , epidemiology, prevalence, causes, risk factors, protective factors, diagnosis, tests, treatments and prevention .
A woman has two ovaries.. The ovaries are a key part of the reproductive system of the females and are the organs responsible for the release of eggs or ova during ovulation . However, like every other organs in the human body, the ovaries can be diseased and become a huge problem to a woman during her life time.
One of the commonest diseases of the ovaries is cancer. Though it is preventable and curable when detected early , ovarian cancer is the third commonest cause of death in women globally and the second commonest gynaecological malignancy worldwide. Studies show that lifetime dying from an ovarian cancer of a woman is almost 1%.
Epidemiology and Prevalence
- Ovarian cancer is a common malignancy with a worldwide distribution but commoner years after menopause; although it has been diagnosed occasionally among pre-menopausal females.
- In general, ovarian cancer is a disease of the postmenopausal woman, with the highest incidence among female ages 60–75 years
The mean age at diagnosis of ovarian cancer is 69 years.
- Ovarian cancer has also been found in women still menstruating so age may sometimes not really be a factor here.
- In Nigeria, ovarian cancer is the third killer of Nigerian women after cervical and breast cancer from epidemiological and clinical studies.
- There is no national study on cancer of the ovaries in Nigeria.
- African–Americans are reported to have a lower incidence of ovarian cancer but have a poorer prognosis compared to their white counterparts.
There are no known actual causes of
ovarian cancer but here here possible risk factors
that makes one stand a high chance of developing this malignancy. They are:
– Age is a risk factor as most cases of ovarian cancer occur after menopause .
– high number of lifetime ovulations (early first menstruation and late menopause): menstruation inflicts repeated injuries in the ovaries making them prone to cancer
– infertility (women unable to achieve pregnancy stand a good chance of developing cancer of the ovaries research repeatedly shown). Women without children also do not breastfeed increasing their risk of cancer.
– family history/genetic inheritance (women whose grandmothers, mothers, aunties or sisters had ovarian malignancy, breast cancer, or uterine cancer stand a high chance of developing cancer of the ovary)
– eating diets high in saturated animal fats exposes women to cancer of the ovaries.
– talcum powder genital exposure (talcum powder rubbed on the pubic area can escape into the vagina and irritate the ovaries)
– use of fertility drugs have be shown to increase the chances of developing cancer of the ovaries that is drugs that stimulates ovulation.
– Previous personal history of breast cancer
– previous personal history of colon cancer
– Previous personal history of uterine cancer
– Genetic mutations in genes that protects women against ovarian and breast cancer called BRCA1 and BRCA2 genes.
Protective Factors against cancer of the ovaries
The following factors protects women against ovarian cancer. These are conditions that basically
decrease the total number of ovulations thereby reducing the possibility of ovarian cancer:
use of oral contraceptive pills
short reproductive life (late first
menstruation and early menopause)
Prophylactic oophorectomy (removal of the ovaries)
Having more children have been found to offer protection against cancer of the ovaries.
Surgeries such as hysterectomy and tubal ligation may confer a weak protective effect against ovarian cancer.
Symptoms and Signs of ovarian cancer
1. Most women with ovarian cancer are asymptomatic and even when they develop symptoms, they are usually non specific.
2. Abdominal swelling/distension
3. Abdominal pain/tenderness
4. Gastrointestinal discomfort/dyspepsia
5. Weight loss/cachexia
6. Loss of appetite/anorexia
9. Leg swelling
10. Easy satiety
11. Breathing difficulty
12. Urinary frequency (frequent urge to urinate)
15. Heart burns
16. Menstrual irregularity in women still seeing their period.
17. Back pains
18. Muscle pains
Types/Classification of ovarian cancer
(A) In terms of cancer origin:
Primary – Arising from the ovary (commoner)
Secondary/Metastatic- Originating from other site(s) or organs and not from the ovary .i.e. spread from other cancerous organs to the ovaries.
(B) In terms of occurrence:
Sporadic- about 90 to 95% of cases.
Familial/Inheritance - about 5 to 10% of cases
(C) In terms of histological cell type:
– Epithelial (commonest)
– Germ cell
– Sex cord and Stromal
(D) Surgical staging and Prognosis (possible outcome).
The diagnosis of cancer of the ovaries starts with history taking and physical evaluation before investigations which will be blood tests radiological, histological and surgical staging.
The tests include:
Baseline Full Blood Count, Electrolytes/
Urea/Creatinine, Liver Function Test
Pelvic UltraSound Scan (USS)
Plain X-Ray (Chest X-ray; Abdominal Xrays)
CT Scan (Abdomen/pelvic)
Tumour markers Ca125, CEA, α-fetoprotein, hCG, LDH, (BRCA 2 gene for familial cases)
Biopsy for histological confirmation/diagnosis
Surgery remains the mainstay with
Total Abdominal Hysterectomy and
bilateral salpingooophorectomy with
omentectomy – TAH + BSO (Debulking
Chemotherapy – Carboplatin &
Paclitaxel usually for Epithelial malignancy
which remain the commonest variant.
For women of reproductive age or if you want to get pregnant in future, your fertility may be preserved through egg freezing, embryo freezing and preservative ovarian surgeries.
In the presence of positive family history &
BRCA2 and BRCA1 gene, there should be:
– Routine tumour markers assay Ca 125, CEA
- Routine and regular pelvic USS
1. [Guideline] American College of Obstetricians and Gynecologists. ACOG Practice Bulletin. Management of adnexal masses
2. Cramer DW, Vitonis AF, Terry KL, Welch WR, Titus LJ. The Association Between Talc Use and Ovarian Cancer: A Retrospective CaseControl Study in Two US States. Epidemiology. 2016 May. 27 (3):33446.
3. Goff BA, Mandel LS, Drescher CW, Urban N, Gough S, Schurman KM, et al. Development of an ovarian cancer symptom index: possibilities for earlier detection. Cancer. 2007 Jan 15. 109(2):2217
4. Stany MP, Maxwell GL, Rose GS. Clinical decision making using ovarian cancer risk assessment. AJR
5. Am J Roentgenol. 2010 Feb. 194(2):33742
Surveillance, Epidemiology, and End Results
Program. Cancer Stat Facts: Ovary Cancer. National Cancer Institute.
6. Featured Image: Cellink
Dr James Chukwuemeka